{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:01:56Z","timestamp":1790622116277,"version":"4.1.0"},"reference-count":54,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Traditional technology used to create cohesive hyaluronic acid (HA) injectables for aesthetic use often relies on increased HA concentration and high crosslinking to maximize strength and robustness. As a result, natural HA integrity may be compromised, leading to less dynamic rheology, difficulty in hyaluronidase degradation, and poor tissue integration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The aim of this study was to demonstrate high projection capability, reversibility, and smooth tissue integration with an HA injectable gel produced from an optimized crosslinking process without high 1,4-butanediol diglycidyl ether modification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>TPVM was created using optimized Preserved Network Technology (PNT+) crosslinking technology and evaluated against the existing US-approved and Conformit\u00e9 Europ\u00e9enne (CE)-marked resilient hyaluronic acid (RHA) fillers (RHA1-RHA4 in Europe, RHA Redensity, RHA2-3, and RHA Dynamic Volume in the United States). Assessments included physicochemical properties, rheology, injectability, hyaluronidase degradation, physician-rated injection ease across 3 indications, and long-term tissue integration in minipigs up to 156 weeks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Despite a modification degree of 2.1%, among the lowest in the marketed fillers, TPVM achieved the highest elastic modulus (G\u2032 = 629 \u00b1 8\u2005Pa), linear viscoelastic region (454 \u00b1 15\u2005Pa), and resistance to compression force (10.5 \u00b1 0.1 N). Injectability was rated \u201cvery easy\u201d or \u201ceasy\u201d in over 94% of cases across midface, chin retrusion, and jawline indications. Like all RHA gels, TPVM reached complete hyaluronidase degradation within 30\u2005min. Histological evaluation at 52 and 156 weeks confirmed smooth tissue integration and progressive gel degradation with no encapsulation or persistent inflammation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Optimized PNT+ crosslinking technology decouples gel mechanical performance from the degree of chemical modification, enabling superior projection capacity while preserving enzymatic reversibility and tissue integration.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/asj\/sjag182","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:30:45Z","timestamp":1790335845000},"source":"Crossref","is-referenced-by-count":0,"title":["Achieving High Projection Without Compromise: Process Optimization of a New Resilient Hyaluronic Acid for Deep Structural Support"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4695-1816","authenticated-orcid":false,"given":"Jimmy","family":"Faivre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Killian","family":"Fl\u00e9geau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Vantou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Melotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Clerc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Bourdon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"2026092814250000300_sjag182-B1","doi-asserted-by":"publisher","first-page":"838","DOI":"10.3390\/pharmaceutics14040838","article-title":"Hyaluronic acid: known for almost a century, but still in vogue","volume":"14","author":"Lierova","year":"2022","journal-title":"Pharmaceutics"},{"key":"2026092814250000300_sjag182-B2","doi-asserted-by":"publisher","DOI":"10.2196\/50403","article-title":"Hyaluronidase for dermal filler complications: review of applications and dosage recommendations. Review","volume":"7","author":"Kroumpouzos","year":"2024","journal-title":"JMIR Dermatol"},{"key":"2026092814250000300_sjag182-B3","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/asj\/sjae009","article-title":"The use of hyaluronidase in aesthetic practice: a comparative study of practitioner usage in elective and emergency situations","volume":"44","author":"Currie","year":"2024","journal-title":"Aesthet Surg J"},{"key":"2026092814250000300_sjag182-B4","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.3390\/diagnostics14151640","article-title":"Review of the adverse effects associated with dermal filler treatments: part I nodules, granuloma, and migration","volume":"14","author":"Hong","year":"2024","journal-title":"Diagnostics"},{"key":"2026092814250000300_sjag182-B5","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.3390\/polym16192739","article-title":"Manufacturing process of hyaluronic acid dermal fillers","volume":"16","author":"Hong","year":"2024","journal-title":"Polymers (Basel)"},{"key":"2026092814250000300_sjag182-B6","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1080\/17434440.2021.2014320","article-title":"Crosslinking hyaluronic acid soft-tissue fillers: current status and perspectives from an industrial point of view","volume":"18","author":"Faivre","year":"2021","journal-title":"Expert Rev Med Devices"},{"key":"2026092814250000300_sjag182-B7","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/3001080","article-title":"Skin cell and tissue responses to cross-linked hyaluronic acid in low-grade inflammatory conditions","volume":"2023","author":"Sanchez","year":"2023","journal-title":"Int J Inflam"},{"key":"2026092814250000300_sjag182-B8","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1007\/s13555-024-01202-3","article-title":"Late-onset reactions after hyaluronic acid dermal fillers: a consensus recommendation on etiology, prevention and management","volume":"14","author":"Baranska-Rybak","year":"2024","journal-title":"Dermatol Ther (Heidelb)"},{"key":"2026092814250000300_sjag182-B9","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1097\/dss.0000000000001814","article-title":"Delayed-onset nodules to differentially crosslinked hyaluronic acids: comparative incidence and risk assessment","volume":"45","author":"Sadeghpour","year":"2019","journal-title":"Dermatol Surg"},{"key":"2026092814250000300_sjag182-B10","doi-asserted-by":"publisher","first-page":"765","DOI":"10.2147\/ccid.S315076","article-title":"Comparative analyses of inflammatory response and tissue integration of 14 hyaluronic acid-based fillers in mini pigs","volume":"14","author":"Choi","year":"2021","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"2026092814250000300_sjag182-B11","doi-asserted-by":"publisher","first-page":"e159","DOI":"10.1097\/dss.0000000000002916","article-title":"Advanced concepts in rheology for the evaluation of hyaluronic acid-based soft tissue fillers","volume":"47","author":"Faivre","year":"2021","journal-title":"Dermatol Surg"},{"key":"2026092814250000300_sjag182-B12","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.3390\/pharmaceutics15112585","article-title":"Strengthening the key features of volumizing fillers: projection capacity and long-term persistence","volume":"15","author":"Fl\u00e9geau","year":"2023","journal-title":"Pharmaceutics"},{"key":"2026092814250000300_sjag182-B13","doi-asserted-by":"publisher","first-page":"707e","DOI":"10.1097\/prs.0000000000005429","article-title":"Rheologic and physicochemical properties used to differentiate injectable hyaluronic acid filler products","volume":"143","author":"Fagien","year":"2019","journal-title":"Plast Reconstr Surg"},{"key":"2026092814250000300_sjag182-B14","doi-asserted-by":"publisher","first-page":"NP402","DOI":"10.1093\/asj\/sjae032","article-title":"Comparison of hyaluronidase-mediated degradation kinetics of commercially available hyaluronic acid fillers in vitro","volume":"44","author":"Faivre","year":"2024","journal-title":"Aesthet Surg J"},{"key":"2026092814250000300_sjag182-B15","doi-asserted-by":"publisher","DOI":"10.1097\/gox.0000000000005457","article-title":"Response of 21 hyaluronic acid fillers to recombinant human hyaluronidase","volume":"11","author":"Park","year":"2023","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"2026092814250000300_sjag182-B16","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1177\/30499240251387458","article-title":"Overfilled face syndrome: a narrative review of the roles of practitioner, patient and product factors in filler-induced facial distortion","volume":"1","author":"Kapoor","year":"2025","journal-title":"Int J Aesthet Plast Surg"},{"key":"2026092814250000300_sjag182-B17","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.2147\/CCID.S539888","article-title":"A review: causes, consequences, and management strategies of facial overfilling","volume":"18","author":"Peng","year":"2025","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"2026092814250000300_sjag182-B18","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1093\/asj\/sjac007","article-title":"Injection guidelines for treating midface volume deficiency with hyaluronic acid fillers: the ATP approach (anatomy, techniques, products)","volume":"42","author":"Trevidic","year":"2022","journal-title":"Aesthet Surg J"},{"key":"2026092814250000300_sjag182-B19","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1097\/prs.0000000000009158","article-title":"Midface multilayering filler injection technique: understanding of the dynamic facial anatomy through a \u201csmiling cadavers\u201d anatomical study","volume":"149","author":"Tr\u00e9vidic","year":"2022","journal-title":"Plast Reconstr Surg"},{"key":"2026092814250000300_sjag182-B20","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1093\/asj\/sjw251","article-title":"New high dose pulsed hyaluronidase protocol for hyaluronic acid filler vascular adverse events","volume":"37","author":"DeLorenzi","year":"2017","journal-title":"Aesthet Surg J"},{"key":"2026092814250000300_sjag182-B21","doi-asserted-by":"publisher","DOI":"10.1097\/gox.0000000000002172","article-title":"Practical approach and safety of hyaluronic acid fillers","volume":"7","author":"Rohrich","year":"2019","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"2026092814250000300_sjag182-B22","first-page":"E61","article-title":"Guideline for the management of hyaluronic acid filler-induced vascular occlusion","volume":"14","author":"Murray","year":"2021","journal-title":"J Clin Aesthet Dermatol"},{"key":"2026092814250000300_sjag182-B23","first-page":"434","article-title":"Pilot comparative study of the topical action of a novel, crosslinked resilient hyaluronic acid on skin hydration and barrier function in a dynamic, three-dimensional human explant model","volume":"15","author":"Sundaram","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"2026092814250000300_sjag182-B24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/dss.0000000000003238","article-title":"Efficacy and safety of a new resilient hyaluronic acid filler in the correction of moderate-to-severe dynamic perioral rhytides: a 52-week prospective, multicenter, controlled, randomized, evaluator-blinded study","volume":"48","author":"Sundaram","year":"2021","journal-title":"Dermatol Surg"},{"key":"2026092814250000300_sjag182-B25","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1111\/jocd.13100","article-title":"Efficacy and safety of a new resilient hyaluronic acid dermal filler, in the correction of moderate-to-severe nasolabial folds: a 64-week, prospective, multicenter, controlled, randomized, double-blind and within-subject study","volume":"18","author":"Kaufman-Janette","year":"2019","journal-title":"J Cosmet Dermatol"},{"key":"2026092814250000300_sjag182-B26","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1097\/dss.0000000000002391","article-title":"Efficacy and safety of two resilient hyaluronic acid fillers in the treatment of moderate-to-severe nasolabial folds: a 64-week, prospective, multicenter, controlled, randomized, double-blinded, and within-subject study","volume":"46","author":"Monheit","year":"2020","journal-title":"Dermatol Surg"},{"key":"2026092814250000300_sjag182-B27","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1097\/dss.0000000000001971","article-title":"Efficacy and safety of 3 new resilient hyaluronic acid fillers, crosslinked with decreased BDDE, for the treatment of dynamic wrinkles: results of an 18-month, randomized controlled trial versus already available comparators","volume":"45","author":"Rzany","year":"2019","journal-title":"Dermatol Surg"},{"key":"2026092814250000300_sjag182-B28","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1111\/jocd.14700","article-title":"Injection techniques for midface volumization using soft tissue hyaluronic acid fillers designed for dynamic facial movement","volume":"21","author":"Galadari","year":"2021","journal-title":"J Cosmet Dermatol"},{"key":"2026092814250000300_sjag182-B29","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1097\/dss.0000000000004625","article-title":"A dynamic, high-stretch resilient hyaluronic acid filler improves fine lines of the cheek and patient-reported outcomes","volume":"51","author":"Alzahrani","year":"2025","journal-title":"Dermatol Surg"},{"key":"2026092814250000300_sjag182-B30","doi-asserted-by":"publisher","first-page":"959","DOI":"10.2147\/ccid.S402315","article-title":"Efficacy and safety of resilient hyaluronic acid fillers injected with a cannula: a randomized, evaluator-blinded, split-face controlled study","volume":"16","author":"Beer","year":"2023","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"2026092814250000300_sjag182-B31","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.16716","article-title":"The role of GLP-1 agonists in esthetic medicine: exploring the impact of semaglutide on body contouring and skin health","volume":"24","author":"Haykal","year":"2025","journal-title":"J Cosmet Dermatol"},{"key":"2026092814250000300_sjag182-B32","doi-asserted-by":"publisher","DOI":"10.1002\/der2.70003","article-title":"Semaglutide \u201cozempic\u201d face and implications in cosmetic dermatology","volume":"5","author":"Montecinos","year":"2024","journal-title":"Dermatol Rev"},{"key":"2026092814250000300_sjag182-B33","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28031003","article-title":"Multidose hyaluronidase administration as an optimal procedure to degrade resilient hyaluronic acid soft tissue fillers","volume":"28","author":"Fl\u00e9geau","year":"2023","journal-title":"Molecules"},{"key":"2026092814250000300_sjag182-B34","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.carbpol.2012.08.066","article-title":"Modification and cross-linking parameters in hyaluronic acid hydrogels\u2014definitions and analytical methods","volume":"91","author":"Kenne","year":"2013","journal-title":"Carbohydr Polym"},{"key":"2026092814250000300_sjag182-B35","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.ejcb.2006.05.009","article-title":"Hyaluronan fragments: an information-rich system","volume":"85","author":"Stern","year":"2006","journal-title":"Eur J Cell Biol"},{"key":"2026092814250000300_sjag182-B36","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.biotechadv.2007.07.001","article-title":"The many ways to cleave hyaluronan","volume":"25","author":"Stern","year":"2007","journal-title":"Biotechnol Adv"},{"key":"2026092814250000300_sjag182-B37","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.carbpol.2018.09.014","article-title":"Facile strategy involving low-temperature chemical cross-linking to enhance the physical and biological properties of hyaluronic acid hydrogel","volume":"202","author":"Baek","year":"2018","journal-title":"Carbohydr Polym"},{"key":"2026092814250000300_sjag182-B38","author":"Lebreton"},{"key":"2026092814250000300_sjag182-B39","author":"Karlsson"},{"key":"2026092814250000300_sjag182-B40","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s12010-019-03022-0","article-title":"Structural modifications and solution behavior of hyaluronic acid degraded with high pH and temperature","volume":"189","author":"de Melo","year":"2019","journal-title":"Appl Biochem Biotechnol"},{"key":"2026092814250000300_sjag182-B41","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1021\/bm040050m","article-title":"Role of the pH on hyaluronan behavior in aqueous solution","volume":"6","author":"Gatej","year":"2005","journal-title":"Biomacromolecules"},{"key":"2026092814250000300_sjag182-B42","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3390\/gels9090733","article-title":"Investigation of crosslinking parameters and characterization of hyaluronic acid dermal fillers: from design to product performances","volume":"9","author":"Pluda","year":"2023","journal-title":"Gels"},{"key":"2026092814250000300_sjag182-B43","doi-asserted-by":"publisher","first-page":"7842","DOI":"10.1039\/D5SM00616C","article-title":"Local deformation and dynamics of cross-linked hyaluronic acid gels at charged interfaces","volume":"21","author":"Dhakal","year":"2025","journal-title":"Soft Matter"},{"key":"2026092814250000300_sjag182-B44","author":"Charton"},{"key":"2026092814250000300_sjag182-B45","doi-asserted-by":"publisher","author":"Moeini","DOI":"10.1016\/j.carbpol.2025.124682"},{"key":"2026092814250000300_sjag182-B46","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3390\/gels11070487","article-title":"A scientific framework for comparing hyaluronic acid filler crosslinking technologies","volume":"11","author":"Puljic","year":"2025","journal-title":"Gels"},{"key":"2026092814250000300_sjag182-B47","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3390\/gels10020101","article-title":"Clinical perspectives on the injectability of cross-linked hyaluronic acid dermal fillers: a standardized methodology for commercial product benchmarking with inter-injector assessments","volume":"10","author":"Micheels","year":"2024","journal-title":"Gels"},{"key":"2026092814250000300_sjag182-B48","doi-asserted-by":"publisher","DOI":"10.1097\/gox.0000000000006560","article-title":"Safety and performance of RHA4 in the midface using the multilayering technique: preclinical and clinical evidence","volume":"13","author":"Fl\u00e9geau","year":"2025","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"2026092814250000300_sjag182-B49","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1021\/acsbiomaterials.0c00295","article-title":"Control of matrix stiffness using methacrylate-gelatin hydrogels for a macrophage-mediated inflammatory response","volume":"6","author":"Zhuang","year":"2020","journal-title":"ACS Biomater Sci Eng"},{"key":"2026092814250000300_sjag182-B50","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1002\/jbm.a.34104","article-title":"The effects of substrate stiffness on the in vitro activation of macrophages and in vivo host response to poly(ethylene glycol)-based hydrogels","volume":"100","author":"Blakney","year":"2012","journal-title":"J Biomed Mater Res A"},{"key":"2026092814250000300_sjag182-B51","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jaad.2020.01.066","article-title":"Retrospective review of delayed adverse events secondary to treatment with a smooth, cohesive 20-mg\/mL hyaluronic acid filler in 4500 patients","volume":"83","author":"Humphrey","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2026092814250000300_sjag182-B52","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1097\/dss.0000000000003541","article-title":"Patient comfort, safety, and effectiveness of resilient hyaluronic acid fillers formulated with different local anesthetics","volume":"48","author":"Kaufman-Janette","year":"2022","journal-title":"Dermatol Surg"},{"key":"2026092814250000300_sjag182-B53","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.3390\/pharmaceutics14081553","article-title":"Comparative preclinical study of lidocaine and mepivacaine in resilient hyaluronic acid fillers","volume":"14","author":"Brusini","year":"2022","journal-title":"Pharmaceutics"},{"key":"2026092814250000300_sjag182-B54","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1039\/D5PM00069F","article-title":"Vascular benefit of the use of mepivacaine as an anaesthetic in resilient hyaluronic acid\u00ae injectables","volume":"2","author":"Faivre","year":"2025","journal-title":"RSC Pharm"}],"container-title":["Aesthetic Surgery Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/asj\/advance-article-pdf\/doi\/10.1093\/asj\/sjag182\/71445264\/sjag182.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/asj\/advance-article-pdf\/doi\/10.1093\/asj\/sjag182\/71445264\/sjag182.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:25:08Z","timestamp":1790619908000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/asj\/advance-article\/doi\/10.1093\/asj\/sjag182\/8842538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":54,"URL":"https:\/\/doi.org\/10.1093\/asj\/sjag182","relation":{},"ISSN":["1090-820X","1527-330X"],"issn-type":[{"value":"1090-820X","type":"print"},{"value":"1527-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"article-number":"sjag182"}}